Previous Article | Next Article 
Journal of Clinical Microbiology, May 2002, p. 1723-1727, Vol. 40, No. 5
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.5.1723-1727.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Evaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test by Using Respiratory and Nonrespiratory Specimens in a Tertiary Care Center Laboratory
Cathal E. O'Sullivan,1 David R. Miller,2 Peggy S. Schneider,2 and Glenn D. Roberts2*
Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892,1
Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, Minnesota 559052
Received 15 January 2002/
Returned for modification 12 February 2002/
Accepted 1 March 2002
The performance of the Amplified Mycobacterium Tuberculosis Direct (AMTD) test (Gen-Probe Inc., San Diego, Calif.) was assessed in a large tertiary care mycobacteriology laboratory. Both acid-fast smear-positive and smear-negative respiratory and nonrespiratory clinical specimens were analyzed. From February 1998 to 4 October 2001, AMTD assays were performed on 391 respiratory specimens and 164 nonrespiratory specimens. The AMTD assay was compared to the "gold standard" of combined culture and clinical diagnosis. The overall sensitivity for all specimens, including those for which no smear result was available, was 91.2%. The overall sensitivities of the assay, including acid-fast smear-positive and -negative specimens, were 97.8 and 77.3% for respiratory and nonrespiratory specimens, respectively. The corresponding specificities for respiratory and nonrespiratory specimens were 99.1 and 98.5%, respectively. The overall specificity for all specimens was 98.9%. Positive and negative predictive values were 93.9 and 99.7% and 91.7 and 96.4% for respiratory and nonrespiratory specimens, respectively. The time saved by using the AMTD test for making a diagnosis of tuberculosis instead of using culture was 8.99 days. Inhibitors to the AMTD assay were found in 3.1% of respiratory specimens and 3.1% of nonrespiratory specimens. The assay, used in a general mycobacteriology laboratory setting, represents an important advance in improving the speed and accuracy of diagnosis in the management of patients with tuberculosis.
* Corresponding author. Mailing address: Division of Clinical Microbiology, Mayo Clinic and Mayo Foundation, 200 First St. SW, Rochester, MN 55905. Phone: (507) 284-3704. Fax: (507) 284-9859. E-mail:
roberts.glenn{at}mayo.edu.
Journal of Clinical Microbiology, May 2002, p. 1723-1727, Vol. 40, No. 5
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.5.1723-1727.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Williams, K. J., Ling, C. L., Jenkins, C., Gillespie, S. H., McHugh, T. D.
(2007). A paradigm for the molecular identification of Mycobacterium species in a routine diagnostic laboratory. J Med Microbiol
56: 598-602
[Abstract]
[Full Text]
-
Greco, S, Girardi, E, Navarra, A, Saltini, C
(2006). Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax
61: 783-790
[Abstract]
[Full Text]
-
Wang, J.-Y., Lee, L.-N., Hsu, H.-L., Hsueh, P.-R., Luh, K.-T.
(2006). Performance Assessment of the DR. MTBC Screen Assay and the BD ProbeTec ET System for Direct Detection of Mycobacterium tuberculosis in Respiratory Specimens.. J. Clin. Microbiol.
44: 716-719
[Abstract]
[Full Text]
-
Wang, J.-Y., Lee, L.-N., Chou, C.-S., Huang, C.-Y., Wang, S.-K., Lai, H.-C., Hsueh, P.-R., Luh, K.-T.
(2004). Performance Assessment of a Nested-PCR Assay (the RAPID BAP-MTB) and the BD ProbeTec ET System for Detection of Mycobacterium tuberculosis in Clinical Specimens. J. Clin. Microbiol.
42: 4599-4603
[Abstract]
[Full Text]
-
Lemaitre, N., Armand, S., Vachee, A., Capilliez, O., Dumoulin, C., Courcol, R. J.
(2004). Comparison of the Real-Time PCR Method and the Gen-Probe Amplified Mycobacterium tuberculosis Direct Test for Detection of Mycobacterium tuberculosis in Pulmonary and Nonpulmonary Specimens. J. Clin. Microbiol.
42: 4307-4309
[Abstract]
[Full Text]
-
Trueba, F., Fabre, M., Saint-Blancard, P.
(2004). Rapid Identification of Mycobacterium genavense with a New Commercially Available Molecular Test, INNO-LiPA MYCOBACTERIA v2. J. Clin. Microbiol.
42: 4403-4404
[Abstract]
[Full Text]
-
Sloutsky, A., Han, L. L., Werner, B. G.
(2004). Practical Strategies for Performance Optimization of the Enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J. Clin. Microbiol.
42: 1547-1551
[Abstract]
[Full Text]
-
Piersimoni, C., Scarparo, C.
(2003). Relevance of Commercial Amplification Methods for Direct Detection of Mycobacterium tuberculosis Complex in Clinical Samples. J. Clin. Microbiol.
41: 5355-5365
[Full Text]
-
Honore-Bouakline, S., Vincensini, J. P., Giacuzzo, V., Lagrange, P. H., Herrmann, J. L.
(2003). Rapid Diagnosis of Extrapulmonary Tuberculosis by PCR: Impact of Sample Preparation and DNA Extraction. J. Clin. Microbiol.
41: 2323-2329
[Abstract]
[Full Text]
-
Mazzarelli, G., Rindi, L., Piccoli, P., Scarparo, C., Garzelli, C., Tortoli, E.
(2003). Evaluation of the BDProbeTec ET System for Direct Detection of Mycobacterium tuberculosis in Pulmonary and Extrapulmonary Samples: a Multicenter Study. J. Clin. Microbiol.
41: 1779-1782
[Abstract]
[Full Text]